Could CAR T-Cells tame MS? new trial launches
Disease control
Not yet recruiting
This early-stage study tests a new treatment called CABA-201 for people with multiple sclerosis (MS). It uses a patient's own immune cells, modified to target and remove certain immune cells that may drive MS. The main goal is to check safety and find the right dose in 12 adults …
Phase: PHASE1, PHASE2 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC